AU2002345121A1 - Products for use in immunosuppressive therapy containing lipoic acid and a calcineurin inhibitor - Google Patents

Products for use in immunosuppressive therapy containing lipoic acid and a calcineurin inhibitor

Info

Publication number
AU2002345121A1
AU2002345121A1 AU2002345121A AU2002345121A AU2002345121A1 AU 2002345121 A1 AU2002345121 A1 AU 2002345121A1 AU 2002345121 A AU2002345121 A AU 2002345121A AU 2002345121 A AU2002345121 A AU 2002345121A AU 2002345121 A1 AU2002345121 A1 AU 2002345121A1
Authority
AU
Australia
Prior art keywords
products
lipoic acid
immunosuppressive therapy
calcineurin inhibitor
therapy containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002345121A
Other languages
English (en)
Inventor
Eero Mervaala
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmaconsult Oy
Original Assignee
Pharmaconsult Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmaconsult Oy filed Critical Pharmaconsult Oy
Publication of AU2002345121A1 publication Critical patent/AU2002345121A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Transplantation (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2002345121A 2001-12-21 2002-06-19 Products for use in immunosuppressive therapy containing lipoic acid and a calcineurin inhibitor Abandoned AU2002345121A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20012565 2001-12-21
FI20012565A FI20012565A (fi) 2001-12-21 2001-12-21 Immunosuppressiivisessa terapiassa käytettäviä tuotteita
PCT/FI2002/000542 WO2003055480A1 (en) 2001-12-21 2002-06-19 Products for use in immunosuppressive therapy containing lipoic acid and a calcineurin inhibitor

Publications (1)

Publication Number Publication Date
AU2002345121A1 true AU2002345121A1 (en) 2003-07-15

Family

ID=8562570

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002345121A Abandoned AU2002345121A1 (en) 2001-12-21 2002-06-19 Products for use in immunosuppressive therapy containing lipoic acid and a calcineurin inhibitor

Country Status (3)

Country Link
AU (1) AU2002345121A1 (fi)
FI (1) FI20012565A (fi)
WO (1) WO2003055480A1 (fi)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4439477C2 (de) * 1994-11-08 1999-10-21 Asta Medica Ag Verwendung von R,S-(+/-)-alpha-Liponsäure, R-(+)-alpha-Liponäure, S-(-)-alpha-Liponsäure in reduzierter oder oxidierter Form oder der Metabolite sowie deren Salze, Ester, Amide zur Behandlung der diabetischen Mikroangiopathie
US5990153A (en) * 1997-05-05 1999-11-23 Wood; John G. Ultrasonicated α-lipoic acid solutions for attenuating microvascular injury
WO2001085206A2 (en) * 2000-05-08 2001-11-15 David Haines Immunosuppressive compositions comprising an immunophilin-binding compound and a gingkolide compound
DE10030378A1 (de) * 2000-06-21 2002-03-14 Audit Inst For Medical Service Neue pharmazeutische Zusammensetzung zur topischen Anwendung von wasserunlöslichen und/oder schwer wasserlöslichen Wirkstoffen
WO2001097832A1 (de) * 2000-06-21 2001-12-27 Audit Institute For Medical Services And Quality Assurance Gmbh Pharmazeutische zubereitungen enthaltend cyclosporine und neutralöle
WO2002017959A2 (en) * 2000-08-28 2002-03-07 Wisconsin Alumni Research Foundation Immunosuppression using piceatannol and a calcineurin inhibitor

Also Published As

Publication number Publication date
FI20012565A (fi) 2003-06-22
FI20012565A0 (fi) 2001-12-21
WO2003055480A1 (en) 2003-07-10

Similar Documents

Publication Publication Date Title
AU2001249799A1 (en) Platform for market programs and trading programs
AU2003268015A1 (en) Packaging and dispensing of rapid dissolve dosage form
AUPQ969800A0 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AU2002328494A1 (en) Drugs containing chymase inhibitor and ACE inhibitor as the active ingredients
AU5326100A (en) Pharmaceutical compositions and methods for use
AU2001244596A1 (en) Indolylpyrrole derivatives and cell death inhibitors
AU2002247726A1 (en) 2-Thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry
AU2003268795A1 (en) Pallets and methods for manufacture and use thereof
HUP0303694A3 (en) Aza-amino acid derivatives and pharmaceutical
AU2002223313A1 (en) Protease inhibitors and their pharmaceutical uses
AU2002342889A1 (en) Anthranilic acid amides and pharmaceutical use thereof
AU1039801A (en) Compounds and their use as cysteine protease inhibitors
AU2002240949A1 (en) Pharmaceutical combined preparations containing aromatase inhibitors and substances having an estrogen effect in addition to the use thereof for producing a medicament for estrogen-replacement-therapy
AU5220800A (en) Combination of mtp inhibitors and lipid reducers and the use thereof in medicaments
AU2002345121A1 (en) Products for use in immunosuppressive therapy containing lipoic acid and a calcineurin inhibitor
AU2002360704A1 (en) Connector for use in packaging aerosol containers
AU2002340328A1 (en) Olanzapine dihydrate-ii a process for its preparation and use thereof
AU6866700A (en) Biscyclopropanecarboxylic acid amide compounds and medicinal use thereof
AU7608100A (en) 1-cyclohexene-1-carboxylic acid and 1-cyclohexene-1-carboxylates as neuraminidase inhibitors
AUPR916301A0 (en) Pyrazolopyridine compound and pharmaceutical use thereof
PL352387A1 (en) Pharmaceutical composition containing sibutramine and a lipase inhibitor
AU2003284061A1 (en) Storage and dispensing system
AUPR606401A0 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AUPR548601A0 (en) Pyrazolopyrazinecompound and pharmaceutical use thereof
AU2001259564A1 (en) Pharmaceutical compositions and methods for use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase